Molly, the second dog in the Mason Bone Cancer Study, just finished her stay at UPenn with Dr. Mason. Her owner, Jenn, says that Molly was fairly comfortable during her stay at the hospital. She received the L. Monocytogenes vaccine on Tuesday, July 24. Molly’s temperature increased two degrees above normal as a result of the bacteria floating around in her system. Jenn also said that Molly’s white blood cell count doubled, but her liver values remained normal.
Molly heads home to New Jersey today, but should return to Philadelphia in about three weeks for her second round of the vaccine. Thanks to Molly’s owner, Jenn, and Rebecca, Molly’s aunt, for the updates. Here’s to hoping that Molly, and all the dogs in the Mason Bone Cancer Study, continue to do well and live long and happy lives!
Make sure you come back to read about Dolly, the third dog in the UPenn clinical trial!